PGP and brain cancer: Similar strategies to interfere with the endogenous processes involved in the regulation of Pgp activity (and the activity of other BBB efflux transporters) exist for brain cancer, ischemia, neuroinflammation, Alzheimer’s disease, and others [8,12,35,54,155,156].